Metraipolis › archive › dc_d1add309fc73

[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma — Europe PMC PMID:42518020

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42518020
DOI
10.1186/s13550-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-17T11:07:30.898Z
SHA-256 of the archived text
a498788e7c326e5fcfb6fe300960b7643c8572729da4fc8756cc4d5d48082cc7
Stable URL of this page
https://metraipolis.com/documento/dc_d1add309fc73

How to cite

[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma — Europe PMC PMID:42518020 — Europe PMC (en), https://europepmc.org/article/MED/42518020 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1add309fc73 (Metraipolis archive dc_d1add309fc73, sha256 a498788e7c326e5fcfb6fe300960b7643c8572729da4fc8756cc4d5d48082cc7)
BibTeX
@misc{dcd1add309fc73,
  title = {[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma — Europe PMC PMID:42518020},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42518020},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1add309fc73; sha256 a498788e7c326e5fcfb6fe300960b7643c8572729da4fc8756cc4d5d48082cc7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518020. Agents can read the archived copy with the MCP tool read_document.